Anticancer Potential of Artocarpus heterophyllus and Ficus racemosa: A Preclinical Evidence Review

Satishkumar Bodele, Sufiyan Ahmad

Abstract


Moraceae yield diverse bioactives with anticancer potential. This review synthesizes preclinical evidence on Artocarpus heterophyllus and Ficus racemosa (syn. F. glomerata), while treating F. carica only as related-species context. Searches in PubMed, Scopus, Web of Science, and Google Scholar (through December 2023) identified in vitro and in vivo studies reporting anticancer endpoints. Potency was standardized to µM for pure compounds and µg/mL for extracts; where multiple observations existed per cell line, medians and interquartile ranges were summarized. Mechanistic support was graded: Tier 0 (phenotypic only), Tier 1 (cell signaling by Western blot/ELISA/IF), Tier 2 (transcript-level), and Tier 3 (in vivo target modulation). Prenylated flavonoids from A. heterophyllus (e.g., artocarpin) showed consistent cytotoxicity with apoptosis and PI3K/Akt involvement (Tiers 1–2), whereas F. racemosa extracts exhibited modest antiproliferative activity with Tier-1 markers. Selectivity was reported when normal-cell comparators were available. Translation is limited by heterogeneous extraction/reporting, sparse animal-tumor studies for F. racemosa, and the absence of clinical trials. Priorities include composition-defined materials, pharmacokinetics/toxicology, and mechanism-anchored in vivo studies.


Keywords


Artocarpus heterophyllus; Ficus racemosa; Moraceae; Prenylated flavonoids; Cytotoxicity; Apoptosis; PI3K/Akt; Selectivity index

Full Text:

PDF

References


P. H. Canter, H. Thomas, and E. Ernst, “Bringing medicinal plants into cultivation: Opportunities and challenges for biotechnology,” Trends in Biotechnology, vol. 23, no. 4, pp. 180–185, 2005. [Online]. Available: https://doi.org/10.3390/molecules26061752

F. M. Jarrett, “Studies in Artocarpus and allied genera, III. A revision of Artocarpus subgenus Artocarpus,” Journal of the Arnold Arboretum, vol. 40, pp. 113–155, 1959. [Online]. Available: https://www.biodiversitylibrary.org/part/186034

E. W. M. Verheij and R. E. Coronel, Eds., Plant Resources of South-East Asia No. 2: Edible Fruits and Nuts. Wageningen, Netherlands: Pudoc/PROSEA, 1991/1992. [Online]. Available: https://external.dandelon.com/download/attachments/dandelon/ids/DE006614AFA47A3371976C1257AC9003C4F32.pdf

P. S. Sreeja Devi, N. S. Kumar, and K. K. Sabu, “Phytochemical profiling and antioxidant activities of different parts of Artocarpus heterophyllus Lam. (Moraceae): A review,” Future Journal of Pharmaceutical Sciences, vol. 7, p. 30, 2021. [Online]. Available: https://doi.org/10.1186/s43094-021-00178-7

K. Shivasharanappa, R. L. Londonkar, and J. V. Hanchinalmath, Ficus glomerata: A Plant that Own Anticancer Compounds. Amazon KDP, 2019. [Online]. Available: https://www.amazon.com/dp/B07T9XJ1SX

L. M. Perry, Medicinal Plants of East and Southeast Asia: Attributed Properties and Uses. Cambridge, MA: MIT Press, 1980. [Online]. Available: https://openlibrary.org/books/OL4421389M

A. Balbach and D. S. F. Boarim, As Plantas que Curam. São Paulo, Brazil: Missão Apostólica, 1992. (Book; no DOI). [Online]. Example catalog: https://www.worldcat.org/title/835197470

Z. Javed et al., “Myricetin: Targeting signaling networks in cancer and its implication in chemotherapy,” Cancer Cell Int., vol. 22, no. 1, Article 239, 2022. [Online]. Available: https://doi.org/10.1186/s12935-022-02663-2

G. Sun, Z. Zheng, M. H. Lee, et al., “Chemoprevention of colorectal cancer by artocarpin, a dietary phytochemical from Artocarpus heterophyllus,” J. Agric. Food Chem., vol. 65, no. 17, pp. 3474–3480, 2017. [Online]. Available: https://doi.org/10.1021/acs.jafc.7b00278

S. B. Swami, N. J. Thakor, P. M. Haldankar, and S. B. Kalse, “Jackfruit and its many functional components as related to human health: A review,” Compr. Rev. Food Sci. Food Saf., vol. 13, no. 4, pp. 395–412, 2014. [Online]. Available: https://doi.org/10.1111/1541-4337.12115

K. Panthong and T. Poonpaiboonpipat, “Antioxidant and antityrosinase activities of Artocarpus lacucha heartwood for medicinal-dyeing,” Curr. Appl. Sci. Technol., vol. 21, no. 2, pp. 316–328, 2021. [Online]. Available: https://li01.tci-thaijo.org/index.php/castwj

A. A. Sule and U. U. Pateh, “Ficus racemosa Linn.—Its uses, pharmacology and taxonomy,” Int. J. Res. Pharm. Sci., vol. 1, no. 4, pp. 417–427, 2010. [Online]. Available: https://ijrps.com/article/famous-tree-ficus-racemosa-its-uses-pharmacology-and-taxonomy/

F. Ahmed and A. Urooj, “Chemopreventive role of Ficus racemosa Linn. fruit extract against carbon tetrachloride-induced oxidative DNA damage and genotoxicity in rats,” Hum. Exp. Toxicol., vol. 29, no. 4, pp. 259–268, 2010. [Online]. Available: https://doi.org/10.1177/0960327110361755

S. C. Mandal, T. K. Maity, J. Das, B. P. Saha, and M. Pal, “Anti-inflammatory evaluation of Ficus racemosa Linn. leaf extract,” J. Ethnopharmacol., vol. 72, pp. 87–92, 2000. [Online]. Available: https://doi.org/10.1016/S0378-8741(00)00213-6

E. H. Hakim, Y. Asnizar, N. Aimi, and M. Kitajima, “Prenylated flavonoids and related compounds of the Indonesian Artocarpus (Moraceae),” J. Nat. Med., vol. 56, no. 6, pp. 239–245, 2002. [Online]. Available: https://doi.org/10.1007/s11418-002-0076-2

S. Kabir, “Jacalin: A jackfruit (Artocarpus heterophyllus) seed-derived lectin of versatile applications in immunobiological research,” J. Immunol. Methods, vol. 212, no. 2, pp. 193–211, 1998. [Online]. Available: https://doi.org/10.1016/S0022-1759(98)00021-0

C.-N. Lin et al., “Anti-inflammatory and cytotoxic constituents from Artocarpus heterophyllus,” J. Nat. Prod., vol. 59, no. 5, pp. 531–534, 1996. [Online]. Available: https://doi.org/10.1021/np960201t

M. Pande and N. Gupta, “Phytochemical evaluation and in vitro antioxidant potential of Ficus glomerata Roxb. fruit,” J. King Saud Univ. Sci., vol. 33, no. 3, p. 101368, 2021. [Online]. Available: https://doi.org/10.1016/j.jksus.2020.101368

Z.-P. Zheng et al., “Chemical components and tyrosinase inhibitors from the twigs of Artocarpus heterophyllus,” J. Agric. Food Chem., vol. 57, no. 15, pp. 6649–6655, 2009. [Online]. Available: https://doi.org/10.1021/jf9014685

E. H. Hakim, S. A. Achmad, L. D. Juliawaty, L. Makmur, Y. M. Syah, N. Aimi, H. Takayama, and E. L. Ghisalberti, “Prenylated flavonoids and related compounds of the Indonesian Artocarpus (Moraceae),” J. Nat. Med., vol. 51, no. 4, pp. 325–336, 1997. [Online]. Available: https://doi.org/10.1007/BF02962067

F. Ahmed and A. Urooj, “Traditional uses, medicinal properties, and phytopharmacology of Ficus racemosa: A review,” Pharmacology & Biology, vol. 48, no. 6, pp. 672–681, 2010. [Online]. Available: https://doi.org/10.3109/13880200903241861

A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008. [Online]. Available: https://doi.org/10.1038/nature07205

W. Li, X. Kong, J. Zhang, and J. Yang, “Long-term intake of sesamin improves left ventricular remodelling in spontaneously hypertensive rats,” Food & Function, vol. 4, pp. 453–460, 2013. [Online]. Available: https://doi.org/10.1039/C2FO30220A

M. Singh and R. Singh, “Anticancer activity of Ficus racemosa Linn. stem bark against human cancer cell lines,” Indian Journal of Experimental Biology, 2018. [Online]. Available: https://dx.doi.org/10.7324/JAPS.2023.134426

E. T. Arung, I. W. Kusuma, K. Shimizu, and R. Kondo, “Artocarpin isolated from Artocarpus heterophyllus heartwood induces apoptosis in breast cancer cells (MCF-7) and exhibits cytotoxic activity on J774.A1 macrophages,” Natural Product Research, vol. 26, no. 13, pp. 1238–1243, 2012. [Online]. Available: https://doi.org/10.1007/s11418-010-0425-6

B.-L. Wei, J.-R. Weng, P.-H. Chiu, C.-F. Hung, J.-P. Wang, and C.-N. Lin, “Antiinflammatory flavonoids from Artocarpus heterophyllus and Artocarpus communis,” Journal of Agricultural and Food Chemistry, vol. 53, no. 10, pp. 3867–3871, 2005. [Online]. Available: https://doi.org/10.1021/jf047873n

M. R. Hasan, B. S. Alotaibi, Z. M. Althafar, A. H. Mujamammi, and J. Jameela, “An update on the therapeutic anticancer potential of Ocimum sanctum L.: ‘Elixir of life’,” Molecules, vol. 28, no. 3, Article 1193, 2023. [Online]. Available: https://doi.org/10.3390/molecules28031193

A. M. Abdel-Aty, M. B. Hamed, W. H. Salama, M. M. Ali, A. S. Fahmy, and S. A. Mohamed, “Ficus carica, Ficus sycomorus and Euphorbia tirucalli latex extracts: Phytochemical screening, antioxidant and cytotoxic properties,” Biocatalysis and Agricultural Biotechnology, vol. 20, Art. 101199, 2019. [Online]. Available: https://doi.org/10.1016/j.bcab.2019.101199

V. V. Patil and V. R. Patil, “Evaluation of anti-inflammatory activity of Ficus carica Linn. leaves,” Indian Journal of Natural Products and Resources, vol. 2, no. 2, pp. 151–155, Jun. 2011. [Online]. Available: https://nopr.niscpr.res.in/handle/123456789/12134

E. T. Arung et al., “Artocarpin-rich wood extract of Artocarpus heterophyllus Lam. inhibits colon cancer growth in mice model,” Journal of Ethnopharmacology, vol. 285, p. 114864, 2022. [Online]. Available: https://doi.org/10.1016/j.jep.2021.114864

F. Sun, X. Y. Zheng, J. Ye, T. T. Wu, J. L. Wang, and W. Chen, “Potential anticancer activity of myricetin in human T24 bladder cancer cells both in vitro and in vivo,” Nutrition and Cancer, vol. 64, no. 4, pp. 599–606, 2012. [Online]. Available: https://doi.org/10.1080/01635581.2012.665564

E. W. C. Chan, S. K. Wong, J. Tangah, and H. T. Chan, “Chemistry and pharmacology of artocarpin: An isoprenyl flavone from Artocarpus species,” Systematic Reviews in Pharmacy, vol. 9, no. 1, pp. 58–63, 2018. [Online]. Available: https://doi.org/10.5530/srp.2018.1.12

N. N. N. M. Daud, A. W. Septama, N. Simbak, N. H. A. Bakar, and E. P. Rahmi, “Synergistic effect of flavonoids from Artocarpus heterophyllus heartwoods on anticancer activity of cisplatin against H460 and MCF-7 cell lines,” Natural Product Sciences, vol. 25, no. 4, pp. 311–316, 2019. [Online]. Available: https://doi.org/10.20307/nps.2019.25.4.311

A. Khan, V. Anand, V. Badrinarayanan, K. Thirunethiran, and P. Natarajan, “In vitro antioxidant and cytotoxicity analysis of leaves of Ficus racemosa,” Free Radicals and Antioxidants, vol. 7, no. 1, pp. 8–12, 2016. [Online]. Available: https://doi.org/10.5530/fra.2017.1.2

L. M. Burci, C. B. da Silva, J. N. Rondon, L. M. da Silva, S. F. de Andrade, O. G. Miguel, J. de F. G. Dias, and M. D. Miguel, “Acute and subacute (28 days) toxicity, hemolytic and cytotoxic effect of Artocarpus heterophyllus seed extracts,” Toxicology Reports, vol. 6, pp. 1304–1308, 2019. [Online]. Available: https://doi.org/10.1016/j.toxrep.2018.02.006

World Health Organization, WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants. Geneva: WHO, 2003. [Online]. Available: https://www.who.int/publications/i/item/9241546271

International Council for Harmonisation (ICH), M3(R2): Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals, 2009. [Online]. Available: https://database.ich.org/sites/default/files/M3_R2__Guideline.pdf

I. J. Morrison, J. Zhang, J. Lin, J. E. Murray, R. Porter, M. K. Langat, N. J. Sadgrove, J. Barker, G. Zhang, and R. Delgoda, “Potential chemopreventive, anticancer and anti-inflammatory properties of a refined artocarpin-rich wood extract of Artocarpus heterophyllus Lam.,” Scientific Reports, vol. 11, Article 6854, Mar. 25, 2021. [Online]. Available: https://doi.org/10.1038/s41598-021-86040-5

J.-L. Wolfender, G. Marti, A. Thomas, and S. Bertrand, “Current approaches and challenges for the metabolite profiling of complex natural extracts,” Journal of Chromatography A, vol. 1382, pp. 136–164, 2015. [Online]. Available: https://doi.org/10.1016/j.chroma.2014.10.091

R. M. Patel and S. K. Patel, “Cytotoxic activity of methanolic extract of Artocarpus heterophyllus against A549, HeLa and MCF-7 cell lines,” Journal of Applied Pharmaceutical Science, vol. 1, no. 7, pp. 167–171, Sept. 2011. [Online]. Available: https://japsonline.com/abstract.php?article_id=197&sts=2

J. K. Patra et al., “Nano based drug delivery systems: recent developments and future prospects,” Journal of Nanobiotechnology, vol. 16, Article 71, 2018. [Online]. Available: https://doi.org/10.1186/s12951-018-0392-8

H. Wagner and G. Ulrich-Merzenich, “Synergy research: approaching a new generation of phytopharmaceuticals,” Phytomedicine, vol. 16, no. 2–3, pp. 97–110, 2009. [Online]. Available: https://doi.org/10.1016/j.phymed.2008.12.018




DOI: https://doi.org/10.37311/ijpe.v5i3.34423

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 Satishkumar Bodele, Sufiyan Ahmad

Creative Commons License
Indonesian Journal of Pharmaceutical Education is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.